Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences (Nasdaq: OACC) is a blank-check company sponsored by an affiliate of Oaktree Capital Management, L.P., the Los Angeles-based alternative asset manager. The vehicle completed its initial public offering in October 2024, making it one of the later-vintage SPACs to price that year, and is focused exclusively on the life sciences sector, including biotechnology, pharmaceuticals, medical technology, and related healthcare subsectors. As of its 424B4 prospectus filing, OACC was in the target-search phase, with management tasked with identifying a merger or acquisition candidate within the life sciences industry. Visit SpacDesk to access the full filing history, trust account details, and deal timeline for OACC and hundreds of other active SPACs.